Showing results (121-130 of 5,439) with videos related to
Sort By:
Pageof 544
Bulletin Du Cancer|March 1, 2018
[Homeopathy in cancer patients: What does the "best" evidence tell us?]Alexandre de Nonneville, Anthony GonçalvesBulletin Du Cancer|February 21, 2018
[Thyroid carcinoma on struma ovarii: Diagnosis and treatment]Coriolan Lebreton, Abir Al Ghuzlan, Anne Floquet, et al.Bulletin Du Cancer|February 25, 2018
[Radiation therapy in inflammatory breast cancer]Pauline Jardel, Zenab Alami, Stéphane Vignot, et al.Bulletin Du Cancer|December 24, 2017
[Epidemiology of pancreatic cancer]Antoine Drouillard, Sylvain Manfredi, Côme Lepage, et al.Bulletin Du Cancer|January 2, 2018
[Atezolizumab (Tecentriq®): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma]Alice Bernard-Tessier, Clément Bonnet, Pernelle Lavaud, et al.Bulletin Du Cancer|December 25, 2018
[Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]John De Vos, Etienne Baudoux, Jacques-Olivier Bay, et al.Bulletin Du Cancer|December 25, 2018
[Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Catherine Faucher, Catherine Adam, Nelly Bancillon, et al.Bulletin Du Cancer|December 6, 2006
A phase II trial of miltefosine in patients with cutaneous T-cell lymphomaCharles Dumontet, Luc Thomas, Frédéric Bérard, et al.Bulletin Du Cancer|December 6, 2006
Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNsRongrong Li, Yufeng Cheng, Chengjin GaoBulletin Du Cancer|December 6, 2006
[Neoadjuvant treatment in osteosarcomas]Chantal Kalifa, Laurence Brugières, Marie-Cécile Le DeleyPageof 544